In the present study, we demonstrated that GPR35 overexpression can promotes anchorage-independent cell growth and YAP/TAZ activity, and this pro-cancer role of constitutive GPR35 activity can be effectively inhibited by its antagonist. Here, GPR35 is linked to cancer.